Likelihood of spontaneous conversion of atrial fibrillation to sinus rhythm

Journal of the American College of Cardiology

Volumn 31, Issue 3, 1998, Pages 588-592

  Danias, Peter G ^a,b   Caulfield, Todd A ^b   Weigner, Marilyn J ^b   Silverman, David I ^a   Manning, Warren J ^b  

^a Cardiol Div of the John Dempsey H   (United States)

^b BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CARDIOVERSION; ECHOCARDIOGRAPHY; FEMALE; HEART ATRIUM FIBRILLATION; HEART LEFT VENTRICLE FUNCTION; HEART OUTPUT; HOSPITAL ADMISSION; HUMAN; MAJOR CLINICAL STUDY; MALE; PREDICTION; PRIORITY JOURNAL; REGRESSION ANALYSIS; SCREENING; SINUS RHYTHM;

EID: 17944390762     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0735-1097(97)00534-2     Document Type: Article

References (30)

1. Ostrander LD Jr, Brandt RL, Kjelsberg MO, Epstein FH. Electrocardiographic findings among the adult population of a total natural community, Tecumseh, Mich. Circulation. 31:1965;888-898.
2. Kannel WB, Abbott RD, Savage DD, McNamara PM. Epidemiologic features of chronic atrial fibrillation the Framingham Study . N Engl J Med. 306:1982;1018-1022.
3. Heart and Stroke Facts. Statistical Supplement. Dallas (Tx): American Heart Association, 1996:14.
4. Pritchett E. Management of atrial fibrillation. N Engl J Med. 326:1992;1264-1271.
5. Prystowsky E, Benson W, Fuster V, et al. Management of patients with atrial fibrillation a statement for health care professionals from the Subcommittee on Electrocardiography and Electrophysiology, American Heart Association . Circulation. 93:1996;1262-1277.
6. Laupacis A, Albers G, Dalen H, Dunn M, Feinberg W, Jacobsen A. Antithrombotic therapy in atrial fibrillation. Chest. 108:(Suppl 4):1995;352S-359S.
7. Weigner MJ, Caulfield TA, Danias PG, Silverman DI, Manning WJ. Risk of clinical thromboembolism associated with cardioversion to sinus rhythm among patients with atrial fibrillation of less than 48 hours' duration. Ann Intern Med. 126:1997;615-620.
8. Falk RH, Knowlton AA, Bernard SA, Gotlieb NE, Battinelli NJ. Digoxin for converting recent-onset atrial fibrillation to sinus rhythm a randomized, double-blinded trial . Ann Intern Med. 106:1987;503-506.
9. Galve E, Ruis T, Ballester R, et al. Intravenous amiodarone in treatment of recent-onset atrial fibrillation results of a randomized, controlled study . J Am Coll Cardiol. 27:1996;1079-1082.
10. Noc M, Stajer D, Horvat M. Intravenous amiodarone versus verapamil for acute conversion of paroxysmal atrial fibrillation to sinus rhythm. Am J Cardiol. 65:1990;679-680.
11. Weiner P, Ganem R, Zidan F, Rabner M. Clinical course of recent-onset atrial fibrillation treated with oral propafenone. Chest. 105:1994;1013-1016.
12. Intravenous digoxin in acute atrial fibrillation results of a randomized, placebo-controlled multicenter trial in 239 patients . Eur Heart J. 18:1997;649-654.
13. Boriani G, Biffi M, Capucci A, et al. Oral propafenone to convert recent-onset atrial fibrillation in patients with and without underlying heart disease a randomized, controlled trial . Ann Intern Med. 126:1997;621-625.
14. Coplen SE, Antmann EM, Berlin JA, Hewitt P, Chalmers TC. Efficacy and safety of quinidine therapy for maintenance of sinus rhythm after cardioversion a meta-analysis of randomized controlled trials . Circulation. 82:1990;1106-1116.
15. Echt DS, Liebson PR, Mitchell LB, et al. Mortality and morbidity in patients receiving encainide, flecainide, or placebo the Cardiac Arrhythmia Suppression Trial . N Engl J Med. 324:1991;781-788.
16. Selzer A, Wray HW. Quinidine syncope paroxysmal ventricular fibrillation occurring during treatment of chronic atrial arrhythmias . Circulation. 30:1964;17-26.
17. Lown B, Perlroth MG, Kaidbey S, Abe T, Harken DE. "Cardioversion" of atrial fibrillation a report on the treatment of 65 episodes in 50 patients . N Engl J Med. 269:1963;325-331.
18. Maisel WH, Kuntz KM, Reimold SC, et al. Risk of initiating antiarrhythmic drug therapy for atrial fibrillation in patients admitted to a university hospital. Ann Intern Med. 127:1997;281-284.
19. Sahn DJ, DeMaria A, Kisslo J, Weyman A. Recommendations regarding quantitation in M-mode echocardiography results of a survey of echocardiographic measurements . Circulation. 58:1978;1072-1083.
20. Anderson S, Blanski L, Byrd RC, et al. for the Esmolol Versus Placebo Multicenter Study Group. Comparison of the efficacy and safety of esmolol, a short-acting beta blocker, with placebo in the treatment of supraventricular tachyarrhythmias. Am Heart J 1986;111:42-8.
21. Shenasa M, Kus T, Fromer M, LeBlanc RA, Dubuc M, Nadeau R. Effect of intravenous and oral calcium antagonists (diltiazem and verapamil) on sustenance of atrial fibrillation. Am J Cardiol. 62:1988;403-407.
22. Suttorp MJ, Kingma JH, Lie-A-Huen L, Mast EG. Intravenous flecainide versus verapamil for acute conversion of paroxysmal atrial fibrillation or flutter to sinus rhythm. Am J Cardiol. 63:1989;693-696.
23. Platia EV, Michelson EL, Porterfield JK, Das G. Esmolol versus verapamil in the acute treatment of atrial fibrillation or atrial flutter. Am J Cardiol. 63:1989;925-929.
24. Juul-Möller S, Edvardson N, Rehnqvist-Ahlberg N. Sotalol versus quinidine for the maintenance of sinus rhythm after direct current conversion of atrial fibrillation. Circulation. 82:1990;1932-1939.
25. Lee SH, Chen SA, Tai CT, et al. Comparisons of oral propafenone and sotalol as an initial treatment in patients with symptomatic paroxysmal atrial fibrillation. Am J Cardiol. 79:1997;905-908.
26. Manning WJ, Silverman DI, Keighley CS, Oettgen P, Douglas PS. Transesophageal echocardiographically facilitated early cardioversion from atrial fibrillation using short-term anticoagulation final results of a prospective 4.5-year study . J Am Coll Cardiol. 25:1995;1354-1361.
27. Bjerkelund C, Orning OM. The efficacy of anticoagulant therapy in preventing embolism related to D.C. electrical conversion of atrial fibrillation. Am J Cardiol. 23:1969;208-216.
28. Klein AL, Grimm RA, Black IW, et al. for the ACUTE Investigators. Cardioversion guided by transesophageal echocardiography: the ACUTE pilot study. Ann Intern Med 1997;126:200-9.
29. Wijffels MC, Kirchhof CJ, Dorland R, Allessie MA. Atrial fibrillation begets atrial fibrillation a study in awake chronically instrumented goats . Circulation. 92:1995;1954-1968.
30. Dittrich HC, Erickson JS, Schneiderman T, Blacky AR, Savides T, Nicod PH. Echocardiographic and clinical predictors for outcome of elective cardioversion of atrial fibrillation. Am J Cardiol. 63:1989;193-197.